A Phase I Trial Using RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer.

Trial Profile

A Phase I Trial Using RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2013

At a glance

  • Drugs Everolimus (Primary) ; Cisplatin
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Feb 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 06 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top